Traduction de «Blood-derived drug » (Anglais → Français) :

blood-derived drug | medically derived blood product | stable blood product | human blood derived product

blood product | blood-derived product | human blood-derived product

blood derivative product

labile (blood) derivatives

stable (blood) derivation

antihypertensive | high blood pressure drug

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

4-aminophenol derivatives nonsteroidal anti-inflammatory drugs [NSAID] pyrazolone derivatives salicylates

Blood-alcohol and blood-drug test

antifibrinolytic | drug to stop breakdown of blood clots

Consultation procedures for drug-device combination products, devices utilising animal tissue, devices utilising human blood derivatives

The supply of blood and blood derivatives, such as plasma-derived drugs, is a matter of life and death for many patients, as many of you have said.

These new proposals form a useful adjunct to an impressive series of recent advances made by the Community under the pharmaceutical programme of the White Paper, in particular the package of measures concerning biotechnological drugs of December 1986 (marketing conditions, clinical trials, protection against copies), the Directive on the transparency of prices and reimbursement of the cost of medicines by the social security systems of December 1988, and the adoption of four framework directives in May and June 1989 which extend the pharmaceutical directives (quality, safety, and effectiveness of drugs) to vaccines, radio-pharmaceuticals ...[+++] and blood derivatives and to products intended for export to the third world.

The proposals adopted today extend the scope of the Community pharmaceuticals Directives to immunological products (vaccines, sera, toxins, allergens), products derived from human blood, radiopharmaceutical drugs and other generic medicines not covered by the definition of proprietary medical products.